Yifan Xinfu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate

Latest as of September 2025: 4.60x

Yifan Xinfu Pharmaceutical Co Ltd cash flow reinvestment rate. Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Cash Flow Reinvestment Rate of 4.60x as of September 2025, reinvesting CN¥184.68 Million (capex CN¥184.68 Million ) from operating cash flow of CN¥40.18 Million. Explore Yifan Xinfu Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

4.60x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥184.68 Million
Capex + Investments

Operating Cash Flow

CN¥40.18 Million
CNY

Capital Expenditures

CN¥184.68 Million
CNY

Cash Flow Reinvestment Rate of Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)

Cash flow reinvestment rate of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. Historical reinvestment intensity for Yifan Xinfu Pharmaceutical Co Ltd across 21 annual periods. Explore Yifan Xinfu Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Yifan Xinfu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2003–2025)

Yifan Xinfu Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2003 to 2025. Year-by-year capital reinvestment analysis for Yifan Xinfu Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Yifan Xinfu Pharmaceutical Co Ltd cash flow conversion.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 1.40x CN¥639.96 Million CN¥458.37 Million CN¥559.23 Million ▲ +26.7%
2024 1.10x CN¥705.83 Million CN¥640.73 Million CN¥628.16 Million ▼ -63.0%
2023 2.97x CN¥1.04 Billion CN¥348.58 Million CN¥504.09 Million ▲ +15.8%
2022 2.57x CN¥1.21 Billion CN¥472.07 Million CN¥542.27 Million ▲ +21.2%
2021 2.12x CN¥638.34 Million CN¥301.23 Million CN¥571.74 Million ▲ +216.7%
2020 0.67x CN¥741.71 Million CN¥1.11 Billion CN¥715.71 Million ▼ -34.2%
2019 1.02x CN¥952.57 Million CN¥937.24 Million CN¥866.07 Million ▼ -7.3%
2018 1.10x CN¥1.28 Billion CN¥1.17 Billion CN¥729.21 Million ▲ +17.4%
2017 0.93x CN¥1.06 Billion CN¥1.13 Billion CN¥485.86 Million ▼ -39.4%
2016 1.54x CN¥1.32 Billion CN¥855.85 Million CN¥287.50 Million ▲ +131.9%
2015 0.66x CN¥267.15 Million CN¥401.96 Million CN¥217.15 Million ▲ +3.8%
2014 0.64x CN¥89.51 Million CN¥139.74 Million CN¥89.51 Million ▼ -70.3%
2013 2.15x CN¥73.95 Million CN¥34.32 Million CN¥73.95 Million ▼ -4.8%
2012 2.26x CN¥67.64 Million CN¥29.88 Million CN¥67.64 Million ▼ -12.3%
2009 2.58x CN¥151.27 Million CN¥58.61 Million CN¥151.27 Million ▲ +75.6%
2008 1.47x CN¥122.46 Million CN¥83.31 Million CN¥122.46 Million ▲ +112.5%
2007 0.69x CN¥172.06 Million CN¥248.71 Million CN¥172.06 Million ▼ -60.8%
2006 1.77x CN¥57.62 Million CN¥32.62 Million CN¥57.62 Million ▼ -27.3%
2005 2.43x CN¥58.63 Million CN¥24.12 Million CN¥58.63 Million ▲ +16.4%
2004 2.09x CN¥70.14 Million CN¥33.59 Million CN¥70.14 Million ▼ -49.6%
2003 4.14x CN¥52.44 Million CN¥12.65 Million CN¥52.44 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow